Detection of circulating tumor necrosis factor after endotoxin administration.
暂无分享,去创建一个
A. Cerami | K. Manogue | D. Spriggs | C. Dinarello | D. Wilmore | S. O'dwyer | H. Michie | S. Wolff | A. Revhaug | K. Manogue | S M Wolff | C A Dinarello | A Cerami | D W Wilmore | H R Michie | K R Manogue | D R Spriggs | A Revhaug | S O'Dwyer | H. R. Michie
[1] M. Rosenblum,et al. Phase I study of recombinant tumor necrosis factor in cancer patients. , 1987, Cancer research.
[2] B. Beutler,et al. Cachectin and tumour necrosis factor as two sides of the same biological coin , 1986, Nature.
[3] J. D. Albert,et al. Shock and tissue injury induced by recombinant human cachectin. , 1986, Science.
[4] H. D. Hochstein,et al. The processing and collaborative assay of a reference endotoxin. , 1983, Journal of biological standardization.
[5] T. Clemmer,et al. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. , 1987, The New England journal of medicine.
[6] C. Dinarello,et al. Development and use of a radioimmunoassay for human interleukin-1 beta. , 1987, Lymphokine research.
[7] J. Mcghee,et al. The primary role of lymphoreticular cells in the mediation of host responses to bacterial endotoxim. , 1980, The Journal of infectious diseases.
[8] R. Albertini,et al. Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. , 1968, Lancet.
[9] B. Beutler,et al. Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. , 1985, Journal of immunology.
[10] D. Wilmore,et al. Combined Hormonal Infusion Simulates the Metabolic Response to Injury , 1984, Annals of surgery.
[11] M. Lumpkin. The regulation of ACTH secretion by IL-1. , 1987, Science.
[12] A. Cerami,et al. Studies of conditions and agents that stimulate and inhibit the production of cachectin by macrophages , 1984 .
[13] B. Beutler,et al. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. , 1985, Science.
[14] C. Dinarello,et al. Biology of interleukin 1 , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] B. Beutler,et al. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. , 1986, Science.
[16] B. Beutler,et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1 , 1986, The Journal of experimental medicine.
[17] B. Beutler,et al. Cachectin: more than a tumor necrosis factor. , 1987, The New England journal of medicine.
[18] Kevin J. Tracey,et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia , 1987, Nature.
[19] J. Vilček,et al. Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma-interferon. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[20] P. Scuderi,et al. RAISED SERUM LEVELS OF TUMOUR NECROSIS FACTOR IN PARASITIC INFECTIONS , 1986, The Lancet.
[21] J. Tavernier,et al. Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma. , 1986, Journal of immunology.
[22] J. Gabrilove,et al. The acute metabolic effects of tumor necrosis factor administration in humans. , 1987, Archives of surgery.